1. Shamshirsaz AA, Bekheirnia MR, Kamgar M,
Pourzahedgilani N, Bouzari N, Habibzadeh
M, et al. Metabolic and endocrinologic
complications in beta-thalassemia major: a
multicenter study in Tehran. BMC Endocr
Disord. 2003 Aug 12;3(1):4.
2. Abolghasemi H, Amid A, Zeinali S, Radfar
MH, Eshghi P, Rahiminejad MS, et al.
Thalassemia in Iran: epidemiology,
prevention, and management. J Pediatr
Hematol Oncol. LWW; 2007;29(4):233–8.
3. Chen M-R, Ko H-S, Chao T-F, Liu H-C, Kuo
J-Y, Bulwer BE, et al. Relation of myocardial
systolic mechanics to serum ferritin level as a
prognosticator in thalassemia patients
undergoing repeated transfusion.
Echocardiography. 2015 Jan;32(1):79–88.
4. Kondur AK, Li T, Vaitkevicius P, Afonso L.
Quantification of myocardial iron overload by
cardiovascular magnetic resonance imaging
T2* and review of the literature. Clin Cardiol.
2009 Jun;32(6):E55–9.
5. Wood JC, Enriquez C, Ghugre N, OttoDuessel M, Aguilar M, Nelson MD, et al.
Physiology and pathophysiology of iron
cardiomyopathy in thalassemia. Ann N Y
Acad Sci. 2005 Jan;1054:386–95.
6. Davis BA, Porter JB. Long-term outcome of
continuous 24-hour deferoxamine infusion via
indwelling intravenous catheters in high-risk
beta-thalassemia. Blood. American Society of
Hematology; 2000 Feb 15;95(4):1229–36.
7. Leonardi B, Margossian R, Colan SD, Powell
AJ. Relationship of magnetic resonance
imaging estimation of myocardial iron to left
ventricular systolic and diastolic function in
thalassemia. JACC Cardiovasc Imaging. 2008
Sep;1(5):572–8.
8. Anderson LJ, Holden S, Davis B, Prescott E,
Charrier CC, Bunce NH, et al. Cardiovascular
T2-star (T2*) magnetic resonance for the early
diagnosis of myocardial iron overload. Eur
Heart J. 2001 Dec;22(23):2171–9.
9. Wood JC, Otto-Duessel M, Aguilar M, Nick
H, Nelson MD, Coates TD, et al. Cardiac iron
determines cardiac T2*, T2, and T1 in the
gerbil model of iron cardiomyopathy.
Circulation. 2005 Jul 26;112(4):535–43.
10. Westwood M, Anderson LJ, Firmin DN,
Gatehouse PD, Charrier CC, Wonke B, et al.
A single breath-hold multiecho T2*
cardiovascular magnetic resonance technique
for diagnosis of myocardial iron overload. J
Magn Reson Imaging. 2003 Jul;18(1):33–9.
11. Felker GM, Thompson RE, Hare JM, Hruban
RH, Clemetson DE, Howard DL, et al.
Underlying Causes and Long-Term Survival
in Patients with Initially Unexplained
Cardiomyopathy. N Engl J Med.
Massachusetts Medical Society; 2000 Apr
13;342(15):1077–84.
12. Küçük NO, Aras G, Sipahi T, Ibiş E, Akar N,
Soylu A, et al. Evaluation of cardiac functions
in patients with thalassemia major. Ann Nucl
Med. 1999 Jun;13(3):175–9.
13. Vogel M, Anderson LJ, Holden S, Deanfield
JE, Pennell DJ, Walker JM. Tissue Doppler
echocardiography in patients with
thalassaemia detects early myocardial
dysfunction related to myocardial iron
overload. Eur Heart J. Eur Soc Cardiology;
2003;24(1):113–9.
14. Chrysohoou C, Greenberg M, Pitsavos C,
Panagiotakos DB, Ladis V, Barbetseas J, et al.
Diastolic Function in Young Patients with
Beta-Thalassemia Major: An
Echocardiographic Study. Echocardiography.
Wiley Online Library; 2006;23(1):38–44.
15. Ghugre NR, Enriquez CM, Gonzalez I,
Nelson MD, Coates TD, Wood JC. MRI
detects myocardial iron in the human heart.
Magn Reson Med. Wiley Online Library;
2006;56(3):681–6.
16. Mavrogeni SI, Markussis V, Kaklamanis L,
Tsiapras D, Paraskevaidis I, Karavolias G, et
al. A comparison of magnetic resonance
imaging and cardiac biopsy in the evaluation
of heart iron overload in patients with β-
thalassemia major. Eur J Haematol. Wiley
Online Library; 2005;75(3):241–7.
17. Aessopos A, Giakoumis A, Fragodimitri C,
Karabatsos F, Hatziliami A, Yousef J, et al.
Correlation of echocardiography parameters
with cardiac magnetic resonance imaging in
transfusion-dependent thalassaemia major.
Eur J Haematol. 2007 Jan;78(1):58–65.